Compare $ATOS vs $SHPH | Chartloom

Compare

$ATOS vs $SHPH

Atossa Therapeutics Inc · Shuttle Pharmaceuticals Holdings Inc

ATOS

Atossa Therapeutics Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Compare $ATOS vs $SHPH

Comparing Atossa Therapeutics Inc and Shuttle Pharmaceuticals Holdings Inc

ATOSAtossa Therapeutics Inc

SHPHShuttle Pharmaceuticals Holdings Inc

ATOSAtossa Therapeutics Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.2%

52W performance

-85.3%

FCF yield

-147.1%

SHPHShuttle Pharmaceuticals Holdings Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.6%

52W performance

-87.9%

FCF yield

-283.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATOS

SHPH

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

ATOS$24M

SHPH$3M

Enterprise Value

ATOS$-2M

SHPH$3M

Price

ATOS$2.44

SHPH$5.33

P/E Ratio

ATOSN/A

SHPHN/A

P/S Ratio

ATOS145.95x

SHPH0.00x

EV/Sales

ATOS-17.14x

SHPH0.00x

EV/EBITDA

ATOS0.00x

SHPH0.00x

P/B Ratio

ATOS0.87x

SHPH5.94x

P/FCF Ratio

ATOSN/A

SHPHN/A

EV/FCF

ATOS0.05x

SHPH-0.34x

PEG Ratio

ATOSN/A

SHPHN/A

Forward P/E (NTM)

ATOSN/A

SHPHN/A

Forward P/S (NTM)

ATOSN/A

SHPHN/A

Revenue (TTM)

ATOS$0

SHPH$0

Revenue Growth (YoY)

ATOSN/A

SHPHN/A

Forward Rev Growth

ATOS184.1%

SHPH0.0%

Gross Margin (TTM)

ATOS62.5%

SHPH0.0%

Operating Margin (TTM)

ATOS0.0%

SHPH0.0%

EBITDA Margin (TTM)

ATOS0.0%

SHPH0.0%

Net Margin (TTM)

ATOS0.0%

SHPH0.0%

FCF Margin (TTM)

ATOSN/A

SHPHN/A

Net Income (TTM)

ATOS$-38M

SHPH$-10M

FCF (TTM)

ATOS$-36M

SHPH$-10M

EPS (TTM)

ATOS-$4.23

SHPH-$10.11

ROE (TTM)

ATOS-10299.0%

SHPH-40833.0%

ROA (TTM)

ATOS-8578.0%

SHPH-13815.0%

ROIC (TTM)

ATOS-10299.0%

SHPH-37757.0%

Cash

ATOS$26M

SHPH$90K

Debt

ATOS$0

SHPH$0

Net Cash/Debt

ATOS$26M

SHPH$90K

Current Ratio (TTM)

ATOS5.69x

SHPH0.30x

Quick Ratio (TTM)

ATOS4.81x

SHPH0.13x

Debt/Equity (TTM)

ATOS0.00x

SHPH1.23x

Debt/Assets (TTM)

ATOS0.0%

SHPH0.0%

Interest Coverage (TTM)

ATOSN/A

SHPHN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

SHPH0.00x

Beta

ATOS1.39

SHPH1.13

52W Performance

ATOS-85.3%

SHPH-87.9%

YTD Performance

ATOS-74.2%

SHPH-70.6%

% from 52W High

ATOS-87.4%

SHPH-90.5%

% from 52W Low

ATOS43.5%

SHPH106.9%

Asset Turnover (TTM)

ATOS0.01x

SHPH0.00x

FCF Yield (TTM)

ATOS-147.1%

SHPH-283.7%

Earnings Yield (TTM)

ATOS-155.0%

SHPH-300.8%

Dividend Yield (TTM)

ATOSN/A

SHPHN/A

Rule of 40

ATOS0.0

SHPH0.0

EV/GP/RG

ATOSN/A

SHPHN/A

Ticker research

View ATOS research View SHPH research

Metric	ATOS Atossa Therapeutics Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$24M	$3M
Enterprise Value	$-2M	$3M
Price	$2.44	$5.33
P/E Ratio	N/A	N/A
P/S Ratio	145.95x	0.00x
EV/Sales	-17.14x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	184.1%	0.0%
Profitability
Gross Margin (TTM)	62.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-10M
FCF (TTM)	$-36M	$-10M
EPS (TTM)	-$4.23	-$10.11
ROE (TTM)	-10299.0%	-40833.0%
ROA (TTM)	-8578.0%	-13815.0%
ROIC (TTM)	-10299.0%	-37757.0%
Financial Health
Cash	$26M	$90K
Debt	$0	$0
Net Cash/Debt	$26M	$90K
Current Ratio (TTM)	5.69x	0.30x
Quick Ratio (TTM)	4.81x	0.13x
Debt/Equity (TTM)	0.00x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	1.13
52W Performance	-85.3%	-87.9%
YTD Performance	-74.2%	-70.6%
% from 52W High	-87.4%	-90.5%
% from 52W Low	43.5%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-147.1%	-283.7%
Earnings Yield (TTM)	-155.0%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View SHPH research

Valuation

P/S Ratio

SHPH

0.00x

ATOS

145.95x

EV/FCF

SHPH

-0.34x

ATOS

0.05x

Growth & revenue

Forward Revenue Growth

ATOS

184.1%

SHPH

0.0%

Profitability & performance

Gross Margin

ATOS

62.5%

SHPH

0.0%

ROE

ATOS

-10299.0%

SHPH

-40833.0%

FCF Yield %

ATOS

-147.1%

SHPH

-283.7%

52-Week Performance

ATOS

-85.3%

SHPH

-87.9%

Detailed metrics comparison

ATOS

Atossa Therapeutics Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

ATOS$24M

SHPH$3M

Enterprise Value

ATOS$-2M

SHPH$3M

Price

ATOS$2.44

SHPH$5.33

P/E Ratio

ATOSN/A

SHPHN/A

P/S Ratio

ATOS145.95x

SHPH0.00x

EV/Sales

ATOS-17.14x

SHPH0.00x

EV/EBITDA

ATOS0.00x

SHPH0.00x

P/B Ratio

ATOS0.87x

SHPH5.94x

P/FCF Ratio

ATOSN/A

SHPHN/A

EV/FCF

ATOS0.05x

SHPH-0.34x

PEG Ratio

ATOSN/A

SHPHN/A

Forward P/E (NTM)

ATOSN/A

SHPHN/A

Forward P/S (NTM)

ATOSN/A

SHPHN/A

Revenue (TTM)

ATOS$0

SHPH$0

Revenue Growth (YoY)

ATOSN/A

SHPHN/A

Forward Rev Growth

ATOS184.1%

SHPH0.0%

Gross Margin (TTM)

ATOS62.5%

SHPH0.0%

Operating Margin (TTM)

ATOS0.0%

SHPH0.0%

EBITDA Margin (TTM)

ATOS0.0%

SHPH0.0%

Net Margin (TTM)

ATOS0.0%

SHPH0.0%

FCF Margin (TTM)

ATOSN/A

SHPHN/A

Net Income (TTM)

ATOS$-38M

SHPH$-10M

FCF (TTM)

ATOS$-36M

SHPH$-10M

EPS (TTM)

ATOS-$4.23

SHPH-$10.11

ROE (TTM)

ATOS-10299.0%

SHPH-40833.0%

ROA (TTM)

ATOS-8578.0%

SHPH-13815.0%

ROIC (TTM)

ATOS-10299.0%

SHPH-37757.0%

Cash

ATOS$26M

SHPH$90K

Debt

ATOS$0

SHPH$0

Net Cash/Debt

ATOS$26M

SHPH$90K

Current Ratio (TTM)

ATOS5.69x

SHPH0.30x

Quick Ratio (TTM)

ATOS4.81x

SHPH0.13x

Debt/Equity (TTM)

ATOS0.00x

SHPH1.23x

Debt/Assets (TTM)

ATOS0.0%

SHPH0.0%

Interest Coverage (TTM)

ATOSN/A

SHPHN/A

Net Debt/EBITDA (TTM)

ATOS0.00x

SHPH0.00x

Beta

ATOS1.39

SHPH1.13

52W Performance

ATOS-85.3%

SHPH-87.9%

YTD Performance

ATOS-74.2%

SHPH-70.6%

% from 52W High

ATOS-87.4%

SHPH-90.5%

% from 52W Low

ATOS43.5%

SHPH106.9%

Asset Turnover (TTM)

ATOS0.01x

SHPH0.00x

FCF Yield (TTM)

ATOS-147.1%

SHPH-283.7%

Earnings Yield (TTM)

ATOS-155.0%

SHPH-300.8%

Dividend Yield (TTM)

ATOSN/A

SHPHN/A

Rule of 40

ATOS0.0

SHPH0.0

EV/GP/RG

ATOSN/A

SHPHN/A

Ticker research

View ATOS research View SHPH research

Metric	ATOS Atossa Therapeutics Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$24M	$3M
Enterprise Value	$-2M	$3M
Price	$2.44	$5.33
P/E Ratio	N/A	N/A
P/S Ratio	145.95x	0.00x
EV/Sales	-17.14x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	0.05x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	184.1%	0.0%
Profitability
Gross Margin (TTM)	62.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-10M
FCF (TTM)	$-36M	$-10M
EPS (TTM)	-$4.23	-$10.11
ROE (TTM)	-10299.0%	-40833.0%
ROA (TTM)	-8578.0%	-13815.0%
ROIC (TTM)	-10299.0%	-37757.0%
Financial Health
Cash	$26M	$90K
Debt	$0	$0
Net Cash/Debt	$26M	$90K
Current Ratio (TTM)	5.69x	0.30x
Quick Ratio (TTM)	4.81x	0.13x
Debt/Equity (TTM)	0.00x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	1.13
52W Performance	-85.3%	-87.9%
YTD Performance	-74.2%	-70.6%
% from 52W High	-87.4%	-90.5%
% from 52W Low	43.5%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-147.1%	-283.7%
Earnings Yield (TTM)	-155.0%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATOS research	View SHPH research